| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0039
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2420-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-9528
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-003 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-148
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-0077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-07 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-14 |
| filingDate |
2015-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2018-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101846769-B1 |
| titleOfInvention |
Partially coated stents |
| abstract |
The medical product includes a biodegradable filament 110 and a non-biodegradable coating 112. The biodegradable filament forms a stent body 100 having a first end portion 104, a middle portion 108 and a second end portion 106 facing the first end portion. The intermediate portion extends between the first end portion and the second end portion. The non-biodegradable coating encapsulates at least one biodegradable monofilament along an intermediate portion of the stent body. The non-biodegradable coating forms a barrier such that the non-biodegradable coating prevents decomposition of at least one biodegradable monofilament along the middle portion. The first end portion and the second end portion are not coated. After implantation, the distal portion of the stent may be biodegradable. The middle portion will not be biodegradable due to its encapsulation by a non-biodegradable coating. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020222364-A1 |
| priorityDate |
2014-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |